Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 0.20 is 92% below its 5-year average of 2.50, near the low end of its 5-year range (0.06–62.34).
As of the fiscal period ended Tuesday, June 30, 2026. 12.37% above its 12-month average of 0.18.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.20.
CURRENT RATIO
0.20
CURRENT RATIO AVG TTM
0.18
CURRENT RATIO AVG 3Y
0.41
CURRENT RATIO AVG 5Y
2.50
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+12.37%
CURRENT VS 3Y AVG
-51.52%
CURRENT VS 5Y AVG
-92.10%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.10
median of 445 covered companies
CURRENT VS SECTOR MEDIAN
-93.64%
vs the sector median at left
Estrella Immunopharma, Inc.
Market Cap
$18.77M
Current Ratio
0.20
TTM Avg
0.18
3Y Avg
0.41
5Y Avg
2.50
Market Cap
$20.93M
Current Ratio
1.25
TTM Avg
1.72
3Y Avg
2.15
5Y Avg
2.15
Market Cap
$16.54M
Current Ratio
1.65
TTM Avg
3.34
3Y Avg
3.94
5Y Avg
7.05
Market Cap
$15.91M
Current Ratio
1.11
TTM Avg
2.09
3Y Avg
1.19
5Y Avg
1.02
Market Cap
$15.30M
Current Ratio
1.24
TTM Avg
4.22
3Y Avg
12.60
5Y Avg
18.98
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Estrella Immunopharma, Inc. (ESLA) | $18.77M | 0.20 | 0.18 | 0.41 | 2.50 |
| Cosmos Health Inc. (COSM)vs › | $18.82M | 1.05 | 0.99 | 1.52 | 1.43 |
| Actuate Therapeutics Inc (ACTU)vs › | $20.93M | 1.25 | 1.72 | 2.15 | 2.15 |
| Bionano Genomics, Inc. (BNGO)vs › | $16.58M | 2.48 | 1.52 | 2.21 | 4.42 |
| Dyadic International, Inc. (DYAI)vs › | $16.54M | 1.65 | 3.34 | 3.94 | 7.05 |
| BioCardia, Inc. (BCDA)vs › | $16.22M | 2.09 | 1.13 | 1.21 | 2.30 |
| Allarity Therapeutics, Inc. (ALLR)vs › | $15.91M | 1.11 | 2.09 | 1.19 | 1.02 |
| Aytu BioPharma, Inc. (AYTU)vs › | $21.90M | 1.13 | 1.19 | 1.11 | 1.05 |
| Cocrystal Pharma, Inc. (COCP)vs › | $15.30M | 1.24 | 4.22 | 12.60 | 18.98 |
| Citius Pharmaceuticals, Inc. (CTXR)vs › | $14.28M | 0.84 | 0.51 | 4.20 | 6.42 |
Current Ratio
0.20
Quick Ratio
0.20
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 0.20 |
| 2026-03-31 | 0.24 |
| 2025-12-31 | 0.12 |
| 2025-09-30 | 0.15 |
| 2025-06-30 | 0.16 |
| 2025-03-31 | 0.22 |
| 2024-12-31 | 0.55 |
| 2024-09-30 | 0.75 |
| 2024-06-30 | 24.65 |
| 2024-03-31 | 62.34 |
| 2023-12-31 | 11.17 |
| 2023-09-30 | 1.58 |
| 2023-06-30 | 0.09 |
| 2023-03-31 | 0.07 |
| 2022-12-31 | 0.64 |
| 2022-09-30 | 0.22 |
| 2022-06-30 | 0.83 |
| 2022-03-31 | 14.18 |
| 2021-12-31 | 8.42 |
| 2021-09-30 | 7.75 |
| 2021-06-30 | 0.06 |
| 2021-02-28 | 0.19 |
